Información del producto
Nombre:
Cilostazol - USP
Sinónimos:
- 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
- 2(1H)-Quinolinone, 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-
- 6-[4-(1-Cyclohexyl-1,2,3,4-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril
- 6-[4-(1-Cyclohexyl-1H-Tetrazol-5-Yl)Butoxy]-3,4-Dihydro-2(1H)-Quinolinone
- 6-[4-(1-Cyclohexyl-5-Tetrazolyl)Butoxy]-1,2,3,4-Tetrahydro-2-Oxoquinolinone
- 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydroquinolin-2(1H)-one
- Cilostazole
- Opc 13013
- Opc 21
- Pletaal
- Ver más sinónimos
- Pletal
- Cilostazol
Descripción:
Cilostazol is a drug used to treat congestive heart failure and intermittent claudication, which is pain caused by poor blood circulation in the legs. It is a controlled-release preparation that is designed to release cilostazol gradually over 12 hours. Cilostazol has been shown to be effective against neuronal death, which may be due to its ability to inhibit cyclic nucleotide phosphodiesterases. The drug also has been shown to increase the production of growth factor-β1 (GF-β1) in vitro models. Cilostazol's effect on the biochemical properties of erythrocytes and platelets have been studied in vivo models.
Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:
Propiedades químicas
Peso molecular:
369.46 g/mol
Fórmula:
C20H27N5O2
Pureza:
Min. 95%
InChI:
InChI=1S/C20H27N5O2/c26-20-12-9-15-14-17(10-11-18(15)21-20)27-13-5-4-8-19-22-23-24-25(19)16-6-2-1-3-7-16/h10-11,14,16H,1-9,12-13H2,(H,21,26)
Clave InChI:
InChIKey=RRGUKTPIGVIEKM-UHFFFAOYSA-N
SMILES:
O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1
MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:
